share_log

Helius Medical Technologies Announces Reimbursement Determination For PoNs Mouthpiece Set At $2,963.30 On Lump Sum Payment To Be Challenged By Co; Disagrees With CMS' Methods, Pricing & Deferral For Determining Payment Rates For PoNs Mouthpiece & Pons...

Helius Medical Technologies Announces Reimbursement Determination For PoNs Mouthpiece Set At $2,963.30 On Lump Sum Payment To Be Challenged By Co; Disagrees With CMS' Methods, Pricing & Deferral For Determining Payment Rates For PoNs Mouthpiece & Pons...

helius medical technologies宣布,PoNs口腔装置套装的报销确定金额为$2,963.30,将由公司提出总额支付挑战;不同意康哲药业的方法、定价和推迟确定PoNs口腔装置和Pons的支付费率。
Benzinga ·  10/14 16:06

Helius Medical Technologies Announces Reimbursement Determination For PoNs Mouthpiece Set At $2,963.30 On Lump Sum Payment To Be Challenged By Co; Disagrees With CMS' Methods, Pricing & Deferral For Determining Payment Rates For PoNs Mouthpiece & Pons Controller

helius medical technologies宣布Pons口罩套装的费用确定为2,963.30美元,即将挑战公司的总额付款;不同意康哲药业的方法、定价和推迟确定Pons口罩和PonsController的付款率。

-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius --

-- 康哲药业挑战Pons口罩(HCPCS代码A4594)的报销确定为2,963.30美元的总额付款 --

-- National Reimbursement Payment Determination from CMS for its PoNS Controller Deferred to the Next Cycle --

-- 康哲药业的PoNS控制器国家报销付款确定由CMS推迟到下一个周期 --

NEWTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare & Medicaid Services (CMS) posted final Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies fee schedule payment rates for the PoNS Mouthpiece (HCPCS code A4594) at $2,963.30 to be implemented January 1, 2025 and deferred final national determination of the payment rate for the PoNS Controller (HCPCS Code A4593) to the next payment cycle.

2024年10月14日,宾夕法尼亚州纽敦(NEWTOWN)(环球新闻社) - Helius Medical Technologies, Inc.(纳斯达克:HSDT)(“Helius”或“公司”)是一家专注于为平衡和步态障碍提供新型治疗性神经调制方法的神经技术公司,今日宣布美国医疗保险和医疗补助服务中心(CMS)发布了PoNS口罩(HCPCS代码A4594)的最终医疗设备,假肢,矫形器和用品的费用表付款率为2,963.30美元,将于2025年1月1日实施,并推迟PoNS控制器(HCPCS代码A4593)的最终国家确定付款率到下一个付款周期。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发